Simul Parikh

University of Pittsburgh

Papers

1

Total Citations

57

H-Index

1

About

Simul Parikh is a leading figure in radiation oncology, with a focused expertise in gastrointestinal malignancies and stereotactic body radiotherapy (SBRT). Her seminal work addresses one of the most challenging clinical scenarios: pancreatic adenocarcinoma with close or positive surgical margins. In her highly cited 2010 study, "Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins," Parikh pioneered the application of SBRT in the adjuvant setting, demonstrating that this precise, high-dose radiation technique could achieve excellent local control with minimal toxicity—a critical advance for a disease with notoriously poor outcomes. Garnering 57 citations, this work has shaped modern treatment paradigms and inspired further investigation into dose escalation and tumor bed targeting. Parikh’s contributions extend beyond this landmark paper; she is recognized for integrating advanced imaging and motion management to enhance SBRT precision, and for her leadership in clinical trials that refine radiation delivery for pancreatic and other abdominal cancers. Her research not only improves survival rates but also reduces treatment burden, making her a transformative voice in oncologic care.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins
57 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Pittsburgh

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago